Table 2.

Level of consensus on statements about patient health-related quality of life targets

Statements	Scores applied, n						Level of consensus, %
	1	2	3	4	5	Total
2.1 Quality of life is an important outcome from the patient and physician perspective and should be included in the therapeutic targets. Achievement of treatment goal implies no impact or minimal impact of the disease on quality of life, e.g. DLQI less than or equal to 3	0	1	2	10	15	28	96
2.2 Treat to target in psoriasis should include patient-centric targets, such as patient satisfaction	0	0	2	15	11	28	100
2.3 If the target of disease-related quality of life is not reached after 3–4 months of therapy, a change in treatment should be considered	1	1	6	12	8	28	93

DLQI Dermatology Life Quality Index